Frontlight ResearchEarly access
CompletedNo phase
Human Papilloma Virus In Male Infertility
Key facts
- Who runs it
- South Valley University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 1 Aug 2023
- Ended
- 10 Aug 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- HPV infection in infertile males
- Record updated
- 13 August 2025
Who can take part
- Age
- 23 years to 53 years
- Sex
- Men only
- Healthy volunteers
- Can take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Patients with at least 1 year of unprotected sexual intercourse without conception
- Patients with genital warts
Who cannot take part
- Hypergonadotropic/hypogonadotropic hypogonadism
- Azoospermia
- chromosome abnormalities
- undescended testis
- mumps orchitis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Infertility is a major health problem worldwide and is estimated to affect 8-12% of couples in the reproductive age group.
Read full original descriptionShow less
Infertility affects both men and women. Male causes for infertility are found in 50% of these couples.
HPV may infect the semen ,allowing it to affect male fertility in a variety of ways.
The 2 groups in the trial
- Infertile Males Group
About 30 infertile males with genital wart
Treatment: HPV infection in infertile males
- Control Group
About 20 healthy males
Treatment: HPV infection in infertile males
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role Of Human Papilloma Virus In Male Infertility In Qena Government - Upper Egypt
- Record updated
- 13 August 2025